Hall, Ryan C.
Ayat, Nadia R.
Qiao, Peter L.
Vaidya, Amita M.
Ma, Dan
Aminoshariae, Anita
Stojanov, Ivan
Lu, Zheng-Rong
Funding for this research was provided by:
National Cancer Institute (R01 CA194518, R01211762, R44 CA199826)
Article History
Received: 11 May 2020
Revised: 7 July 2020
Accepted: 28 July 2020
First Online: 12 August 2020
Compliance with Ethical Standards
:
: ZRL is a co-founder of Molecular Theranostics, LLC, which is focused on the commercialization of targeted MRI contrast agents.